Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Effects of BMS-986036 in Adults With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated:  1/17/2018
Brooke Army Medical Center
mi
from
Fort Sam Houston, TX
A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Effects of BMS-986036 in Adults With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated: 1/17/2018
Brooke Army Medical Center
mi
from
Fort Sam Houston, TX
Click here to add this to my saved trials
A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Effects of BMS-986036 in Adults With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated:  1/17/2018
Texas Liver Institute
mi
from
San Antonio, TX
A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Effects of BMS-986036 in Adults With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated: 1/17/2018
Texas Liver Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Effects of BMS-986036 in Adults With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated:  1/17/2018
Digestive and Liver Disease Specialists
mi
from
Norfolk, VA
A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Effects of BMS-986036 in Adults With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated: 1/17/2018
Digestive and Liver Disease Specialists
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Effects of BMS-986036 in Adults With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated:  1/17/2018
Virginia Commonwealth University
mi
from
Richmond, VA
A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Effects of BMS-986036 in Adults With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated: 1/17/2018
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Effects of BMS-986036 in Adults With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated:  1/17/2018
Unc Hospitals And Clinics
mi
from
Chapel Hill, NC
A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Effects of BMS-986036 in Adults With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated: 1/17/2018
Unc Hospitals And Clinics
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Effects of BMS-986036 in Adults With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated:  1/17/2018
St. Luke'S Episcopal Hospital - Baylor College Of Medicine
mi
from
Houston, TX
A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Effects of BMS-986036 in Adults With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated: 1/17/2018
St. Luke'S Episcopal Hospital - Baylor College Of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Per-Oral Endoscopic Myotomy for Esophageal Swallowing Disorders
Prospective Evaluation of Per-Oral Endoscopic Myotomy (POEM) of the Lower Esophageal Sphincter for the Treatment of Esophageal Swallowing Disorders
Status: Enrolling
Updated:  1/17/2018
Baylor University Medical Center
mi
from
Dallas, TX
Per-Oral Endoscopic Myotomy for Esophageal Swallowing Disorders
Prospective Evaluation of Per-Oral Endoscopic Myotomy (POEM) of the Lower Esophageal Sphincter for the Treatment of Esophageal Swallowing Disorders
Status: Enrolling
Updated: 1/17/2018
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Prevention of Amputation in Diabetic Foot Ulcers Using Amniotic Tissue
Prevention of Amputation in a High Risk Population With Comprehensive Care and Amniotic Tissue
Status: Enrolling
Updated:  1/17/2018
Boise VAMC
mi
from
Boise, ID
Prevention of Amputation in Diabetic Foot Ulcers Using Amniotic Tissue
Prevention of Amputation in a High Risk Population With Comprehensive Care and Amniotic Tissue
Status: Enrolling
Updated: 1/17/2018
Boise VAMC
mi
from
Boise, ID
Click here to add this to my saved trials
A Sub-study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple Dose Sub-study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Effects of BMS-986036 in Adults With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated:  1/17/2018
Thomas Jefferson University Hospital
mi
from
Philadelphia, PA
A Sub-study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple Dose Sub-study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Effects of BMS-986036 in Adults With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated: 1/17/2018
Thomas Jefferson University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Sub-study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple Dose Sub-study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Effects of BMS-986036 in Adults With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated:  1/17/2018
Texas Liver Institute
mi
from
San Antonio, TX
A Sub-study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple Dose Sub-study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Effects of BMS-986036 in Adults With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated: 1/17/2018
Texas Liver Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
Evaluation of Performance Characteristics of Capsule Endoscopy With PillCam UGI Capsule Compared to Standard Endoscopy
Evaluation of Performance Characteristics of Capsule Endoscopy With PillCam UGI Capsule Compared to Standard Endoscopy for Screening of Barrett's Esophagus: A Prospective Tandem Study
Status: Enrolling
Updated:  1/17/2018
Kansas City VA Medical Center
mi
from
Kansas City, MO
Evaluation of Performance Characteristics of Capsule Endoscopy With PillCam UGI Capsule Compared to Standard Endoscopy
Evaluation of Performance Characteristics of Capsule Endoscopy With PillCam UGI Capsule Compared to Standard Endoscopy for Screening of Barrett's Esophagus: A Prospective Tandem Study
Status: Enrolling
Updated: 1/17/2018
Kansas City VA Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Efficacy of Vitamin D Supplementation in Bariatric Surgery Patients
Preoperative Vitamin D Status and Efficacy of Therapeutic Vitamin D Supplementation Postoperatively in Bariatric Surgery Patients
Status: Enrolling
Updated:  1/18/2018
Methodist Hospital
mi
from
Houston, TX
Efficacy of Vitamin D Supplementation in Bariatric Surgery Patients
Preoperative Vitamin D Status and Efficacy of Therapeutic Vitamin D Supplementation Postoperatively in Bariatric Surgery Patients
Status: Enrolling
Updated: 1/18/2018
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Veritas in Non-Bridging Ventral Hernia Repair
Veritas in Non-Bridging Ventral Hernia Repair
Status: Enrolling
Updated:  1/18/2018
Mayo Clinic Department of Surgery
mi
from
Jacksonville, FL
Veritas in Non-Bridging Ventral Hernia Repair
Veritas in Non-Bridging Ventral Hernia Repair
Status: Enrolling
Updated: 1/18/2018
Mayo Clinic Department of Surgery
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Veritas in Non-Bridging Ventral Hernia Repair
Veritas in Non-Bridging Ventral Hernia Repair
Status: Enrolling
Updated:  1/18/2018
Watson Clinic Center for Research
mi
from
Lakeland, FL
Veritas in Non-Bridging Ventral Hernia Repair
Veritas in Non-Bridging Ventral Hernia Repair
Status: Enrolling
Updated: 1/18/2018
Watson Clinic Center for Research
mi
from
Lakeland, FL
Click here to add this to my saved trials
Veritas in Non-Bridging Ventral Hernia Repair
Veritas in Non-Bridging Ventral Hernia Repair
Status: Enrolling
Updated:  1/18/2018
Atlanta Colon & Rectal Surgery, P.A.
mi
from
Atlanta, GA
Veritas in Non-Bridging Ventral Hernia Repair
Veritas in Non-Bridging Ventral Hernia Repair
Status: Enrolling
Updated: 1/18/2018
Atlanta Colon & Rectal Surgery, P.A.
mi
from
Atlanta, GA
Click here to add this to my saved trials
Veritas in Non-Bridging Ventral Hernia Repair
Veritas in Non-Bridging Ventral Hernia Repair
Status: Enrolling
Updated:  1/18/2018
Pratt Medical Center
mi
from
Fredericksburg, VA
Veritas in Non-Bridging Ventral Hernia Repair
Veritas in Non-Bridging Ventral Hernia Repair
Status: Enrolling
Updated: 1/18/2018
Pratt Medical Center
mi
from
Fredericksburg, VA
Click here to add this to my saved trials
Once-Daily Oral Avatrombopag Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures
A Phase 2, Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Efficacy, Safety, and Population Pharmacokinetics of Once-Daily Oral E5501 Tablets Used Up to 7 Days in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures
Status: Enrolling
Updated:  1/19/2018
Ochsner Clinic Foundation
mi
from
New Orleans, LA
Once-Daily Oral Avatrombopag Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures
A Phase 2, Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Efficacy, Safety, and Population Pharmacokinetics of Once-Daily Oral E5501 Tablets Used Up to 7 Days in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures
Status: Enrolling
Updated: 1/19/2018
Ochsner Clinic Foundation
mi
from
New Orleans, LA
Click here to add this to my saved trials
Deviating the Esophagus in Atrial Fibrillation Ablation
Esophageal Deviation in Atrial Fibrillation Ablation: A Randomized Control Trial
Status: Enrolling
Updated:  1/19/2018
Massachusetts General Hospital
mi
from
Boston, MA
Deviating the Esophagus in Atrial Fibrillation Ablation
Esophageal Deviation in Atrial Fibrillation Ablation: A Randomized Control Trial
Status: Enrolling
Updated: 1/19/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Deviating the Esophagus in Atrial Fibrillation Ablation
Esophageal Deviation in Atrial Fibrillation Ablation: A Randomized Control Trial
Status: Enrolling
Updated:  1/19/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Deviating the Esophagus in Atrial Fibrillation Ablation
Esophageal Deviation in Atrial Fibrillation Ablation: A Randomized Control Trial
Status: Enrolling
Updated: 1/19/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Deviating the Esophagus in Atrial Fibrillation Ablation
Esophageal Deviation in Atrial Fibrillation Ablation: A Randomized Control Trial
Status: Enrolling
Updated:  1/19/2018
Texas Cardiac Arrhythmia Institute
mi
from
Austin, TX
Deviating the Esophagus in Atrial Fibrillation Ablation
Esophageal Deviation in Atrial Fibrillation Ablation: A Randomized Control Trial
Status: Enrolling
Updated: 1/19/2018
Texas Cardiac Arrhythmia Institute
mi
from
Austin, TX
Click here to add this to my saved trials
Deviating the Esophagus in Atrial Fibrillation Ablation
Esophageal Deviation in Atrial Fibrillation Ablation: A Randomized Control Trial
Status: Enrolling
Updated:  1/19/2018
Florida Hospital
mi
from
Orlando, FL
Deviating the Esophagus in Atrial Fibrillation Ablation
Esophageal Deviation in Atrial Fibrillation Ablation: A Randomized Control Trial
Status: Enrolling
Updated: 1/19/2018
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
Probability Ramp Control of Propofol for EGD
A Prospective, Randomized Comparison of Depth of Sedation With Propofol Titrated by Probability Ramp Control to Control by Anesthesia Providers During Esophagogastroduodenoscopy (EGD)
Status: Enrolling
Updated:  1/19/2018
Endoscopy Center, Perelman Center for Advanced Medicine
mi
from
Philadelphia, PA
Probability Ramp Control of Propofol for EGD
A Prospective, Randomized Comparison of Depth of Sedation With Propofol Titrated by Probability Ramp Control to Control by Anesthesia Providers During Esophagogastroduodenoscopy (EGD)
Status: Enrolling
Updated: 1/19/2018
Endoscopy Center, Perelman Center for Advanced Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions
Status: Enrolling
Updated:  1/19/2018
Novum Pharmaceutical Research Services
mi
from
Houston, TX
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions
Status: Enrolling
Updated: 1/19/2018
Novum Pharmaceutical Research Services
mi
from
Houston, TX
Click here to add this to my saved trials
Bioequivalency Study of Balsalazide Capsules Under Fasting Conditions
A Single Dose, Two-Period, Two-Treatment, Randomized Crossover Bioequivalency Study of 750 mg Balsalazide Capsules Under Fasting Conditions
Status: Enrolling
Updated:  1/19/2018
Novum Pharmaceuticals Research Services
mi
from
Houston, TX
Bioequivalency Study of Balsalazide Capsules Under Fasting Conditions
A Single Dose, Two-Period, Two-Treatment, Randomized Crossover Bioequivalency Study of 750 mg Balsalazide Capsules Under Fasting Conditions
Status: Enrolling
Updated: 1/19/2018
Novum Pharmaceuticals Research Services
mi
from
Houston, TX
Click here to add this to my saved trials
Bioequivalency Study of Buprenorphine Hydrochloride 8 mg Tablet Under Fasted Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalency Study of Buprenorphine HCl (Sublingual) 8 mg Tablets With a Naltrexone Block Under Fasting Conditions
Status: Enrolling
Updated:  1/19/2018
CEDRA Clinical Research, LLC
mi
from
Austin, TX
Bioequivalency Study of Buprenorphine Hydrochloride 8 mg Tablet Under Fasted Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalency Study of Buprenorphine HCl (Sublingual) 8 mg Tablets With a Naltrexone Block Under Fasting Conditions
Status: Enrolling
Updated: 1/19/2018
CEDRA Clinical Research, LLC
mi
from
Austin, TX
Click here to add this to my saved trials
Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium
Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium
Status: Enrolling
Updated:  1/23/2018
University of Southern California
mi
from
Los Angeles, CA
Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium
Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium
Status: Enrolling
Updated: 1/23/2018
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium
Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium
Status: Enrolling
Updated:  1/23/2018
University of Rochester
mi
from
Rochester, NY
Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium
Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium
Status: Enrolling
Updated: 1/23/2018
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium
Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium
Status: Enrolling
Updated:  1/23/2018
University of Pittsburgh
mi
from
Pittsburgh, PA
Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium
Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium
Status: Enrolling
Updated: 1/23/2018
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium
Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium
Status: Enrolling
Updated:  1/23/2018
AMC
mi
from
Amsterdam,
Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium
Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium
Status: Enrolling
Updated: 1/23/2018
AMC
mi
from
Amsterdam,
Click here to add this to my saved trials
Safety of Lactobacillus Reuteri (L. Reuteri) in Healthy Adults
Phase I Safety and Tolerance of Lactobacillus Reuteri in Adults
Status: Enrolling
Updated:  1/23/2018
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Safety of Lactobacillus Reuteri (L. Reuteri) in Healthy Adults
Phase I Safety and Tolerance of Lactobacillus Reuteri in Adults
Status: Enrolling
Updated: 1/23/2018
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Comparison of Bowel Ultrasound & MR Enterography in the Follow-up of Previously Diagnosed Pediatric Small Bowel Crohn Disease
Comparison of Bowel Ultrasound & MR Enterography in the Follow-up of Previously Diagnosed Pediatric Sm. Bowel Crohn Disease.
Status: Enrolling
Updated:  1/23/2018
University of Michigan Hospital
mi
from
Ann Arbor, MI
Comparison of Bowel Ultrasound & MR Enterography in the Follow-up of Previously Diagnosed Pediatric Small Bowel Crohn Disease
Comparison of Bowel Ultrasound & MR Enterography in the Follow-up of Previously Diagnosed Pediatric Sm. Bowel Crohn Disease.
Status: Enrolling
Updated: 1/23/2018
University of Michigan Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Understanding Patient's Knowledge and Use of Acetaminophen
Understanding Patient's Knowledge and Use of Acetaminophen
Status: Enrolling
Updated:  1/24/2018
The Children's Hospital of Philadelphia, University of Pennsylvania
mi
from
Philadelphia, PA
Understanding Patient's Knowledge and Use of Acetaminophen
Understanding Patient's Knowledge and Use of Acetaminophen
Status: Enrolling
Updated: 1/24/2018
The Children's Hospital of Philadelphia, University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Understanding Patient's Knowledge and Use of Acetaminophen
Understanding Patient's Knowledge and Use of Acetaminophen
Status: Enrolling
Updated:  1/24/2018
Baylor College of Medicine
mi
from
Houston, TX
Understanding Patient's Knowledge and Use of Acetaminophen
Understanding Patient's Knowledge and Use of Acetaminophen
Status: Enrolling
Updated: 1/24/2018
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Understanding Patient's Knowledge and Use of Acetaminophen
Understanding Patient's Knowledge and Use of Acetaminophen
Status: Enrolling
Updated:  1/24/2018
Harris County Hospital District Outpatient Clinics
mi
from
Houston, TX
Understanding Patient's Knowledge and Use of Acetaminophen
Understanding Patient's Knowledge and Use of Acetaminophen
Status: Enrolling
Updated: 1/24/2018
Harris County Hospital District Outpatient Clinics
mi
from
Houston, TX
Click here to add this to my saved trials
Understanding Patient's Knowledge and Use of Acetaminophen
Understanding Patient's Knowledge and Use of Acetaminophen
Status: Enrolling
Updated:  1/24/2018
Kelsey Seybold
mi
from
Houston, TX
Understanding Patient's Knowledge and Use of Acetaminophen
Understanding Patient's Knowledge and Use of Acetaminophen
Status: Enrolling
Updated: 1/24/2018
Kelsey Seybold
mi
from
Houston, TX
Click here to add this to my saved trials
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  1/25/2018
GSK Investigational Site
mi
from
Aurora, CO
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 1/25/2018
GSK Investigational Site
mi
from
Aurora, CO
Click here to add this to my saved trials
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  1/25/2018
GSK Investigational Site
mi
from
New Haven, CT
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 1/25/2018
GSK Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  1/25/2018
GSK Investigational Site
mi
from
Jacksonville, FL
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 1/25/2018
GSK Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  1/25/2018
GSK Investigational Site
mi
from
Boston, MA
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 1/25/2018
GSK Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  1/25/2018
GSK Investigational Site
mi
from
Rochester, MN
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 1/25/2018
GSK Investigational Site
mi
from
Rochester, MN
Click here to add this to my saved trials
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  1/25/2018
GSK Investigational Site
mi
from
Austin, TX
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 1/25/2018
GSK Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  1/25/2018
GSK Investigational Site
mi
from
Richmond, VA
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 1/25/2018
GSK Investigational Site
mi
from
Richmond, VA
Click here to add this to my saved trials
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  1/25/2018
GSK Investigational Site
mi
from
Little Rock, AZ
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 1/25/2018
GSK Investigational Site
mi
from
Little Rock, AZ
Click here to add this to my saved trials
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  1/25/2018
GSK Investigational Site
mi
from
Tucson, AZ
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 1/25/2018
GSK Investigational Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  1/25/2018
GSK Investigational Site
mi
from
La Jolla, CA
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 1/25/2018
GSK Investigational Site
mi
from
La Jolla, CA
Click here to add this to my saved trials
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  1/25/2018
GSK Investigational Site
mi
from
Denver, CO
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 1/25/2018
GSK Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  1/25/2018
GSK Investigational Site
mi
from
Littleton, CO
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 1/25/2018
GSK Investigational Site
mi
from
Littleton, CO
Click here to add this to my saved trials
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  1/25/2018
GSK Investigational Site
mi
from
Hamden, CT
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 1/25/2018
GSK Investigational Site
mi
from
Hamden, CT
Click here to add this to my saved trials
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  1/25/2018
GSK Investigational Site
mi
from
Washington,
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 1/25/2018
GSK Investigational Site
mi
from
Washington,
Click here to add this to my saved trials
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  1/25/2018
GSK Investigational Site
mi
from
Port Orange, FL
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 1/25/2018
GSK Investigational Site
mi
from
Port Orange, FL
Click here to add this to my saved trials